Blockchain across Oracle

Current inefficiencies of medical research

• Hundreds of billions of dollars are wasted in the industry on paperwork, primarily administrative in nature.
• Funding for important government or large foundation research continues to decline, as drug companies prioritize maximizing profits rather than solving difficult health problems.
• Research papers are not shared to foster broader breakthroughs and become siloed.
• Almost all clinical trials end in failure, costing nearly a billion dollars each. Meanwhile, the industry is still fighting cancer with chemotherapy.
• Large companies such as Pfizer are dropping important research on Alzheimer's while giving priority to more lucrative drugs with lower risks, such as Viagra.

Nano Vision is still developing ...